Received in the Senate and Read twice and referred to the Committee on the Judiciary.
The HALT Fentanyl Act creates a broad, class‑based Schedule I listing for “fentanyl‑related substances,” amends penalties and import/export rules to reference that class, and requires the Attorney General to issue implementing rules within six months. It also creates expedited registration and notification procedures to facilitate federally funded or FDA‑regulated research on Schedule I substances, allows limited research‑related manufacture and single institutional registrations, adds transparency requirements for special procedures, and makes technical corrections to prior law.
Progressives emphasize research and civil‑liberty risks; conservatives emphasize enforcement benefits.
Relative to its intended legislative type, this bill is a well-specified statutory package that creates and integrates a class-wide scheduling regime for fentanyl-related substances and accompanying procedural changes for research and enforcement.
The HALT Fentanyl Act creates a broad, class‑based Schedule I listing for “fentanyl‑related substances,” amends penalties and import/export rules to reference that class, and requires the Attorney General to issue implementing rules within six months.
It also creates expedited registration and notification procedures to facilitate federally funded or FDA‑regulated research on Schedule I substances, allows limited research‑related manufacture and single institutional registrations, adds transparency requirements for special procedures, and makes technical corrections to prior law.
The Act applies on enactment and directs an OIG study on fentanyl research.
Strong enforcement appeal but high legal and scientific controversy plus implementation complexity reduce overall odds absent broad bipartisan consensus or compromise.
Relative to its intended legislative type, this bill is a well-specified statutory package that creates and integrates a class-wide scheduling regime for fentanyl-related substances and accompanying procedural changes for research and enforcement. It supplies detailed operational mechanisms, responsible actors, and deadlines, and it amends specific statutory provisions directly.
Progressives emphasize research and civil‑liberty risks; conservatives emphasize enforcement benefits.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize research and civil‑liberty risks; conservatives emphasize enforcement benefits.
Generally supportive of strong measures to reduce overdose deaths, but wary of class‑wide Schedule I control that could hinder medical research, access to pain treatment, and disproportionately affect communities of color.
The bill's research facilitation provisions reduce some concerns, but ambiguity in the chemical definition and immediate scheduling raise civil‑liberty and public‑health process worries.
Sees the bill as a pragmatic federal response to a lethal public‑health and law‑enforcement problem, noting helpful research‑friendly provisions.
Concerned about administrative overreach, legal clarity, and rapid interim rules; would back the bill if implementation includes clear regulations and safeguards against unintended consequences.
Likely favorable as a strong enforcement‑oriented measure targeting illicit fentanyl manufacture and trafficking; views class scheduling as an effective way to target novel synthetic analogues.
May want assurance the bill results in vigorous enforcement and international interdiction, and could accept research facilitation if it does not impede law enforcement.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Strong enforcement appeal but high legal and scientific controversy plus implementation complexity reduce overall odds absent broad bipartisan consensus or compromise.
The House passed this bill. It now goes to the other chamber, and eventually to the President for signature.
The final vote on whether the bill becomes law (pending the other chamber and the President).
This amendment was rejected and will not be added to the bill.
An amendment modifies the text of a bill.
Progressives emphasize research and civil‑liberty risks; conservatives emphasize enforcement benefits.
Strong enforcement appeal but high legal and scientific controversy plus implementation complexity reduce overall odds absent broad biparti…
Relative to its intended legislative type, this bill is a well-specified statutory package that creates and integrates a class-wide scheduling regime for fentanyl-related substances and accompanying procedural changes f…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.